NCT04495504View on ClinicalTrials.gov

Administration of Ropivacaine by Bi-laterosternal Multiperforated Catheters Placed Before a Sternotomy for Cardiac Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

January 12, 2021

Study Completion Date

July 12, 2021

Conditions
Scheduled Cardiac SurgeryAge Under 85 Years
Interventions
DRUG

Ropivacaine

Administration of a bolus dose of 10 ml of ropivacaine 7, 5 mg/mL in each catheter Continuous infusion of ropivacaine 2 mg/ml in a rate of 3 mL/h during the first 48 hours postoperatively.

Trial Locations (1)

63000

CHU Clermont-Ferrand - Service de Chirurgie Cardio-Vasculaire, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT04495504 - Administration of Ropivacaine by Bi-laterosternal Multiperforated Catheters Placed Before a Sternotomy for Cardiac Surgery | Biotech Hunter | Biotech Hunter